Condition

Neuroblastoma

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 34 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials34

Recruiting4

Common interventions25

Lead sponsors shown15

Clinical trials

34 shown

Biomarkers of Resiliency In Childhood Cancer SurgeryNCT06674811 · 2025-01-15

Agnostic Therapy in Rare Solid TumorsNCT06638931 · 2024-07-16

18F-DOPA II - PET Imaging OptimizationNCT04706910 · 2021-01-20

Familial Investigations of Childhood Cancer PredispositionNCT03050268 · 2017-04-06

Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.NCT07595666 · 2025-09-30

ENROLLING_BY_INVITATION

Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid TumorNCT04864821 · 2021-05-14

Dynamic Whole Body Positron Emission Tomography/Computed Tomography ImagingNCT04017104 · 2019-11-01

DOTATOC PET/CT for Imaging NET PatientsNCT03583528 · 2018-07-11

ACTIVE_NOT_RECRUITING

18F-DOPA PET Imaging: an Evaluation of Biodistribution and SafetyNCT03042416 · 2017-06-29

T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing MalignanciesNCT02457650 · 2015-04-01

Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical ImagingNCT01482741 · 2011-11-01

Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic SyndromeNCT00946283 · 2010-03-01

Genomic Structural Variation in Cancer SusceptibilityNCT00996710 · 2009-10-01

ACTIVE_NOT_RECRUITING

Blood Samples From Patients on a Clinical Trial to CINV During HSCTNCT00900068 · 2008-08-01

Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell TransplantNCT00602446 · 2007-08-01

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell TransplantNCT00900406 · 2007-01-01

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantNCT00651716 · 2006-12-01

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantNCT00410657 · 2006-07-01

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantNCT00324324 · 2006-05-01

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerNCT00445965 · 2006-01-01

Campath-1H + FK506 and Methylprednisolone for GVHDNCT00109993 · 2005-01-01

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell TransplantNCT00293384 · 2004-10-01

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell TransplantationNCT00064311 · 2003-06-01

Study of the Emotional Needs of Caregivers of Stem Cell Transplantation PatientsNCT00082654 · 2002-03-01

Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid TumorsNCT00004157 · 2000-08-01

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or ColonNCT00010283 · 2000-07-01

Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed NeuroblastomaNCT00025623 · 1999-07-01

Combination Chemotherapy in Treating Infants With Newly Diagnosed NeuroblastomaNCT00025610 · 1999-07-01

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationNCT00003887 · 1998-08-01

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerNCT00003408 · 1998-04-01

Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine CytoprotectNCT00003425 · 1997-12-01

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsNCT00003107 · 1997-10-01

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal CancerNCT00003022 · 1997-04-01

Prevalence+Significance of Paraneoplastic Autoantibodies in Many CancersNCT00608452 · 1995-07-01

Common interventions

Leading sponsors

Fred Hutchinson Cancer Center 5 Memorial Sloan Kettering Cancer Center 5 British Columbia Cancer Agency 2 European Infant Neuroblastoma Study Group - 1999 2 OHSU Knight Cancer Institute 2 University of Alberta 2 Vanderbilt-Ingram Cancer Center 2 Barbara Ann Karmanos Cancer Institute 1 Cancer Treatment Centers of America 1 Case Comprehensive Cancer Center 1 Indiana University 1 Instituto do Cancer do Estado de São Paulo 1 Masonic Cancer Center, University of Minnesota 1 Mayo Clinic 1 National Institutes of Health Clinical Center (CC) 1

Trial status mix

COMPLETED19

TERMINATED5

RECRUITING4

UNKNOWN3

ACTIVE_NOT_RECRUITING2

ENROLLING_BY_INVITATION1

Phase mix

PHASE213

PHASE16

NA4

PHASE33

EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.